Please login to the form below
Representatives from Boehringer Ingelheim, Pfizer, UCB announced as judges for eyeforpharma Barcelona Awards
eyeforpharma has released the names of the first judges to make up the panel of industry experts judging the inaugural eyeforpharma Barcelona Awards, made up of top individuals from companies such as Pfizer, UCB, Boehringer Ingelheim and Bayer.
Top pharma minds including C-Level executives from Boehringer
Ingelheim, Baxter, Janssen and UCB, together with a range of notable academics
and stakeholders, make up the panel.
When asked why he was getting involved with the awards judge Allan Hillgrove, Board Member for Sales and Marketing at Boehringer Ingelheim said; “Innovation is crucial for the pharmaceutical industry in order to allow it to continue to contribute to the health of patients, and to society. This innovation takes many forms, all of which should add value to our multitude of customers. It is my pleasure to be involved as a judge of the eyeforpharma awards which celebrate this innovation.”
Adding to this sentiment, judge Lode Dewulf, Chief Patient Officer at UCB pointed out; “recognizing patient-centric innovation that brings real value is an important way to support leadership and best practice in this area,” while Ray Chepesiuk, Commissioner of the PAAB commented; “celebrating innovation that drives customer value is a good direction for this industry. We should recognize truly innovative people as a model to make their high standards the norm.”
The newly created awards differ from other pharmaceutical award ceremonies: instead of focussing on sales and marketing performance, the focus is on patient service, customer centricity and innovating for value.
Commenting on this approach, Matt Portch, VP of Commercial Model Innovation for Pfizer expanded: “The dramatic evolution of the healthcare marketplace demands a new and different way to address their needs. I was glad to see that eyeforpharma has identified that as well, and that they are focusing on innovation, patients and customer centricity, as I believe those areas of focus will be the key to pharma’s relevance and success in the future.
Nominations for the awards will be open until 20th December 2013 and winners will be announced on 18th March 2014 in Barcelona.
Visit www.eyeforpharma.com/barcelona/awards for more information and to register your nominations.
When asked why he was getting involved with the awards judge Allan Hillgrove, Board Member for Sales and Marketing at Boehringer Ingelheim said; “Innovation is crucial for the pharmaceutical industry in order to allow it to continue to contribute to the health of patients, and to society. This innovation takes many forms, all of which should add value to our multitude of customers. It is my pleasure to be involved as a judge of the eyeforpharma awards which celebrate this innovation.”
Adding to this sentiment, judge Lode Dewulf, Chief Patient Officer at UCB pointed out; “recognizing patient-centric innovation that brings real value is an important way to support leadership and best practice in this area,” while Ray Chepesiuk, Commissioner of the PAAB commented; “celebrating innovation that drives customer value is a good direction for this industry. We should recognize truly innovative people as a model to make their high standards the norm.”
The newly created awards differ from other pharmaceutical award ceremonies: instead of focussing on sales and marketing performance, the focus is on patient service, customer centricity and innovating for value.
Commenting on this approach, Matt Portch, VP of Commercial Model Innovation for Pfizer expanded: “The dramatic evolution of the healthcare marketplace demands a new and different way to address their needs. I was glad to see that eyeforpharma has identified that as well, and that they are focusing on innovation, patients and customer centricity, as I believe those areas of focus will be the key to pharma’s relevance and success in the future.
Nominations for the awards will be open until 20th December 2013 and winners will be announced on 18th March 2014 in Barcelona.
Visit www.eyeforpharma.com/barcelona/awards for more information and to register your nominations.
